| abstract |
The present invention relates to novel products having the formula (I), wherein R4 represents H, CH3, CH2CH3, CF3, F, Cl, Br, I; Het is one or more R1 or R′1 Represents a heterocycle optionally substituted by a group, wherein the one or more R1 or R'1 groups are H, halogen, CF3, nitro, cyano, alkyl, hydroxy, mercapto, amino, alkylamino, dialkylamino, Alkoxy, phenylalkoxy, alkylthio, carboxy, carboxamide, CO-NH (alkyl), CON (alkyl) 2, NH-CO-alkyl, sulfonamide, NH, free or esterified with an alkyl group Selected from -SO2-alkyl, S (O) 2-NHalkyl, S (O2) -N (alkyl) 2, All of the alkyl, alkoxy and alkylthio groups are optionally substituted; R is selected from the group comprising (A ′), (B), (C), (D) and (E), wherein W1, W2 and W3 independently represent CH or N, X represents O, S, NR2, C (O), S (O) or S (O) 2, and V represents H, Hal, —O—R 2 or —NH—R 2, where R 2 represents H, optionally substituted alkyl, cycloalkyl or heterocycloalkyl. It relates to products which are in isomeric form and their salts and are intended for use as drugs. |